925 Chestnut Street
Mezzanine
Philadelphia, PA 19107
(215) 955-2636
(215) 503-7420 fax
Mezzanine
Philadelphia, PA 19107
(215) 955-2636
(215) 503-7420 fax
Most Recent Peer-reviewed Publications
- Saphenous vein graft disease: Review of pathophysiology, prevention, and treatment
- Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: Analysis from the HF-ACTION DNA substudy
- Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)
- Heart Failure Patient Adherence. Epidemiology, Cause, and Treatment
- Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics
- Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting
- Physical activity to combat depression in chronic heart failure: Reply
- Relation between volume of exercise and clinical outcomes in patients with heart failure
- Long-term exercise training and adheren It is not just exercise
- Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: Findings from HF-ACTION
- Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization
- Effects of exercise training on depressive symptoms in patients with chronic heart failure: The HF-ACTION randomized tria
- Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) Trial
- Predicting costs among medicare beneficiaries with heart failure
- Change in intrathoracic impedance measures during acute decompensated heart failure admission: Results from the diagnostic data for discharge in heart failure patients (3D-HF) pilot study
- Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
- Introduction of the tools for economic analysis of patient management interventions in heart failure costing tool a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions
- Galectin-3 in ambulatory patients with heart failure results from the HF-ACTION study
- Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction the HF-ACTION predictive risk score model
- Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study